Angiographic predictors of reocclusion after thrombolysis: Results from the thrombolysis in myocardial infarction (TIMI) 4 trial

This publication has 36 references indexed in Scilit:

• Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: Angiographic results of the APRICOT study
  Journal of the American College of Cardiology, 1993
• The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.
  Circulation, 1993
• Irregular coronary lesion morphology after thrombolysis predicts early clinical instability
  Journal of the American College of Cardiology, 1991
• Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.
  Circulation, 1990
• Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator.
  Circulation, 1989
• Usefulness of recanalization to luminal diameter of 0.6 millimeter or more with intracoronary streptokinase during acute myocardial infarction in predicting “normal” perfusion status, continued arterial patency and survival at one year
  The American Journal of Cardiology, 1987
• Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction
  The American Journal of Cardiology, 1986
• Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.
  Circulation, 1984
• Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study.
  Heart, 1983